老虎证券

美股详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Purple Biotech Ltd.

2.68
+0.04161.58%
成交量：3,663.00
成交额：9,904.36
市值：710.14万
市盈率：-0.61
高：2.78
开：2.64
低：2.64
收：2.64
数据加载中...
总览公司新闻公告
2025/03/10

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/07/27

SEC问询函

Form CORRESP - Correspondence
2024/07/22

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/03/05

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/14

SEC问询函

Form CORRESP - Correspondence
2023/11/14

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2023/10/31

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2023/05/18

SEC问询函

Form CORRESP - Correspondence
2023/04/03

SEC问询函

CORRESP [Cover] - Correspondence
2023/03/03

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/04/04

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/09

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/04/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/03/16

[修订]年度报告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/16

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/02

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/05

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
更多